
AI Agents for Oncology EHRs
Triomics is building the agentic AI layer for oncology EHRs. Cancer hospitals spend billions on highly trained staff manually reading unstructured patient records - pathology reports, clinical notes, genomic panels - to power workflows like trial matching, registry curation, visit prep, and quality reporting. We replace that manual work with task-driven AI agents that sit inside the EMR and process records at scale, in real time.
Our platform is trusted by the 4 of the top 10 Best Hospitals for Cancer by U.S.News and several of the largest community practices. We have grown 10x in the last year and process millions of oncology medical documents monthly.
Our investors include Lightspeed, General Catalyst, Nexus Venture Partners and Y-Combinator.
Own day-to-day production health and customer issue resolution across our deployments. Issues here range from data ingestion failures and document processing pipeline errors to AI extraction accuracy problems and clinical UI bugs. You investigate, resolve what you can, escalate the rest with full context, and communicate clearly with clinical teams who depend on the platform daily.
Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our GenAI engine, OncoLLM™—an advanced family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.